Indirect payments from drug companies to doctors for CME courses will be exempt from databaseBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6676 (Published 05 November 2014) Cite this as: BMJ 2014;349:g6676
- Nigel Hawkes
A new US database designed to show how much money has been paid to doctors by drug and device manufacturers will exclude a wide range of payments made indirectly through companies that organize continuing medical education (CME) courses.
Critics say that the rule change, announced this week by the Centers for Medicare and Medicaid Services,1 will dilute the benefits of transparency that the database was designed to bring. It means that companies can provide money to intermediaries who organize CME events, who can in turn pay doctors to give talks, without disclosing the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial